Rare Sarcomas
Livrare gratis la comenzi peste 500 RON. Pentru celelalte comenzi livrarea este 20 RON.
Disponibilitate: La comanda in aproximativ 4 saptamani
Editura: Springer
Limba: Engleza
Nr. pagini: 164
Coperta: Hardcover
Dimensiuni: 15.49 x 23.5 cm
An aparitie: 2020
Description:
This is a unique book focusing on the management of rare sarcomas, which pose an important challenge in Europe and in the US, as they represent nearly one quarter of all new diagnoses of cancer and have lower survival rates than common cancer. Discussing a range of tumors from clear cell and epithelioid sarcoma to solitary fibrous tumor and myxoid fibrosarcoma, this book provides invaluable expertise according to evidence-based guidelines and uses a patient-centered multi-disciplinary approach. Each of the chapters discusses the forms of rare sarcomas both from an oncological and a pathological perspective. This book aims to help the sarcoma expert in improving the management, quality of care and outcome for patients with rare tumors, which have now been recognised as a public health priority. The authors are experts from specialist sarcoma centers focusing on the capacity to develop clinical guidelines, and to foster clinical, translational and epidemiological research for rare cancers.
Table of Contents:
1. Clear Cell Sarcoma
2. Epithelioid Sarcoma
3. PEComas: An Uncommon Family of Sarcomas Sensitive to Targeted Therapy
4. Desmoplastic Small Round Cell Tumors
5. Solitary Fibrous Tumours
6. Alveolar Soft Part Sarcoma
7. Epithelioid Hemangioendothelioma
8. Low Grade Fibromyxoid Sarcoma/Sclerosing Epithelioid Fibrosarcoma
9. New Born and Infant Soft Tissue Sarcomas
An aparitie | 2020 |
Autor | Chevreau, Christine, Italiano, Antoine |
Dimensiuni | 15.49 x 23.5 cm |
Editura | Springer |
Format | Hardcover |
ISBN | 9783030246969 |
Limba | Engleza |
Nr pag | 164 |
-
1,20900 lei 1,08500 lei
-
1,12000 lei 1,00000 lei
Clientii ebookshop.ro nu au adaugat inca opinii pentru acest produs. Fii primul care adauga o parere, folosind formularul de mai jos.